Neng Yu

1.8k total citations
57 papers, 945 citations indexed

About

Neng Yu is a scholar working on Immunology, Endocrinology, Diabetes and Metabolism and Hematology. According to data from OpenAlex, Neng Yu has authored 57 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 16 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Hematology. Recurrent topics in Neng Yu's work include T-cell and B-cell Immunology (21 papers), Immune Cell Function and Interaction (18 papers) and Diabetes Management and Education (9 papers). Neng Yu is often cited by papers focused on T-cell and B-cell Immunology (21 papers), Immune Cell Function and Interaction (18 papers) and Diabetes Management and Education (9 papers). Neng Yu collaborates with scholars based in United States, Taiwan and Mexico. Neng Yu's co-authors include M. Ohashi, Tatiana Lebedeva, Edmond J. Yunis, Wayne Huey‐Herng Sheu, Olga P. Clavijo, Harriet Noreen, Stephen R. Spellman, Cynthia Vierra‐Green, Shih‐Tzer Tsai and Carolyn Katovich Hurley and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Neng Yu

52 papers receiving 907 citations

Peers

Countries citing papers authored by Neng Yu

Since Specialization

Citations

This map shows the geographic impact of Neng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neng Yu more than expected).

Fields of papers citing papers by Neng Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neng Yu. The network helps show where Neng Yu may publish in the future.

Co-authorship network of co-authors of Neng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Neng Yu. A scholar is included among the top collaborators of Neng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neng Yu. Neng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterisation of the Novel HLA‐A23:23:02* Allele by Next Generation Sequencing 2025 ·HLA ·Varun Kesherwani, Abdelhamid Liacini, M. Ohashi, (unknown), Neng Yu	0
2	Association between intrinsic capacity and sarcopenia in older adults with type 2 diabetes: A cross-sectional study 2025 ·Aging Clinical and Experimental Research ·Chia‐Ling Lin, (unknown), Neng Yu, (unknown), (unknown), (unknown)	0
3	Real-world Benefits of Diabetes Management App Use and Self-monitoring of Blood Glucose on Glycemic Control: Retrospective Analyses 2022 ·JMIR mhealth and uhealth ·(unknown), (unknown), Hung‐Yi Chiou, (unknown), Neng Yu	3
4	Current HLA testing recommendations to support HCT 2022 ·Human Immunology ·Neng Yu, Medhat Askar, (unknown), Loren Gragert, Marcelo Fernández-Viña	8
5	A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan 2015 ·Atherosclerosis ·(unknown), Masumi Ai, Eiichiro Kanda, Neng Yu, (unknown), (unknown), Minghui Cheng, Takuji Kohzuma, Ernst J. Schaefer, Masayuki Yoshida	24
6	The development of a questionnaire measure of diabetes-related distress in Chinese-speaking patients: the Diabetes-Related Distress Questionnaire (DRDQ) 2015 ·Quality of Life Research ·(unknown), Neng Yu, Wayne Huey‐Herng Sheu, Mei Chang Yeh	1
7	HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients 2015 ·PLoS ONE ·Tatiana Sofia Rodrı́guez-Reyna, (unknown), Neng Yu, (unknown), M. Ohashi, Tatiana Lebedeva, Alfredo Cruz‐Lagunas, Carlos A. Núñez‐Álvarez, (unknown), Gilberto Vargas‐Alarcón, Julio Granados, Joaquı́n Zúñiga, Edmond J. Yunis	18
8	Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes 2014 ·Primary care diabetes ·Shi-Dou Lin, Shih‐Tzer Tsai, Shih‐Te Tu, Ching‐Chieh Su, Jung‐Fu Chen, Chieh‐Hsiang Lu, Chao‐Hung Wang, Neng Yu, (unknown), Ming‐Chia Hsieh	12
9	Differences in the perceptions of self-care, health education barriers and educational needs between diabetes patients and nurses 2013 ·Contemporary Nurse ·Shu‐Fang Vivienne Wu, Heng‐Hsin Tung, Shu‐Yuan Liang, Mei‐Chen Lee, Neng Yu	1
10	HLA Class I and Class II Conserved Extended Haplotypes and Their Fragments or Blocks in Mexicans: Implications for the Study of Genetic Diversity in Admixed Populations 2013 ·PLoS ONE ·Joaquı́n Zúñiga, Neng Yu, Rodrigo Barquera, (unknown), M. Ohashi, Tatiana Lebedeva, Víctor Acuña-Alonzo, (unknown), Julio Granados‐Montiel, Alfredo Cruz‐Lagunas, Gilberto Vargas‐Alarcón, Tatiana Sofia Rodrı́guez-Reyna, Marcelo Fernández-Viña, Julio Granados, Edmond J. Yunis	52
11	Accountability, utilization and providers for diabetes management in Taiwan, 2000–2009: An analysis of the National Health Insurance database 2012 ·Journal of the Formosan Medical Association ·Tien‐Jyun Chang, Yi‐Der Jiang, Chia‐Hsuin Chang, Ching‐Hu Chung, Neng Yu, Lee‐Ming Chuang	31
12	Trends of ABC control 2006–2011: A National Survey of Diabetes Health Promotion Institutes in Taiwan 2012 ·Diabetes Research and Clinical Practice ·Neng Yu, (unknown), Shu‐Ti Chiou, Mei Chang Yeh, (unknown), (unknown), Wayne Huey‐Herng Sheu	56
13	Resolution of HLA class I sequence‐based typing ambiguities by group‐specific sequencing primers 2011 ·Tissue Antigens ·Tatiana Lebedeva, (unknown), (unknown), M. Ohashi, (unknown), Neng Yu	10
14	High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study 2009 ·BMC Cancer ·David Cantú de León, Delia Pérez‐Montiel, (unknown), Alejandro García Carrancá, Alejandro Mohar Betancourt, Víctor Acuña-Alonzo, (unknown), Gilberto Vargas‐Alarcón, Rodrigo Barquera, Neng Yu, Edmond J. Yunis, Julio Granados	20
15	Typing of potential and selected donors for transplant: methodology and resolution 2007 ·Tissue Antigens ·Machteld Oudshoorn, Péter Horn, (unknown), Neng Yu	17
16	Emerging new alleles suggest high diversity of HLA‐C locus 2005 ·Tissue Antigens ·Tatiana Lebedeva, M. Ohashi, (unknown), Sidra Ezídio Gonçalves Vasconcellos, Susan Flesch, Neng Yu	18
17	The recombinant HLA‐B5518 allele supports the evidence of conserved haplotype association of rare alleles 2005 ·Tissue Antigens* ·Tatiana Lebedeva, (unknown), M. Ohashi, (unknown), (unknown), Jane Kempenich, Neng Yu	7
18	Identification of novel HLA class I alleles using single allele sequencing 2003 ·Tissue Antigens ·Tatiana Lebedeva, (unknown), (unknown), M. Lau, Neng Yu	3
19	An initial assessment of the feasibility and effectiveness of implementing diabetes shared care system in Taiwan—some experiences from I-Lan County 2001 ·Diabetes Research and Clinical Practice ·Shu-Ti Chiou, Hong-Da Lin, Neng Yu, (unknown), (unknown), (unknown), (unknown), Mei‐Shu Lai	24
20	Typing of HLA‐B15 alleles using sequence‐specific primers 1998 ·Tissue Antigens* ·Neng Yu, M. Ohashi, (unknown), (unknown), Kaiyuan Cao, Marcelo Fernández-Viña, Edmond J. Yunis	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact